Biotech Conference Season 2026: Which Events Move Stocks the Most

Biotech conferences are where companies present clinical data for the first time, announce partnerships, and reveal pipeline updates. For traders, conference season creates some of the most predictable volatility windows of the year. Knowing which conferences matter — and when — gives you a significant edge.

The Big 5: Must-Watch Conferences

1. JPM Healthcare Conference (January)

The unofficial kickoff to the biotech year. Over 175,000 professionals descend on San Francisco for a week of presentations, meetings, and deal-making. Companies often announce partnerships, pipeline updates, and guidance for the year. The most important week in biotech.

2. ASCO Annual Meeting (May/June)

The largest oncology conference in the world. Abstract data is released 2-3 weeks before the meeting, creating an initial move, followed by a second move during presentations. Late-breaking abstracts can move stocks 30-50% in a single session. If you trade oncology biotech, ASCO is the Super Bowl.

3. AACR Annual Meeting (April)

The premier cancer research conference. More focused on early-stage data and novel mechanisms than ASCO. Companies often present Phase 1/2 data here that generates excitement for later-stage trials. Great for finding early-stage opportunities.

4. ASH Annual Meeting (December)

The definitive hematology conference. Blood cancer drugs, gene therapies, and cell therapies dominate. Abstract releases in November create pre-conference trading opportunities. Companies like BioAtla, Fate Therapeutics, and CRISPR often present key data here.

5. AAN Annual Meeting (April)

The top neurology conference. With Alzheimer disease, Parkinson disease, and rare neurological conditions attracting massive investment, AAN presentations can move neurology-focused biotechs significantly.

How to Trade Conference Season

The Pre-Conference Run-Up

Stocks with presentations at major conferences typically run up 2-4 weeks before the event. The market prices in optimism, creating a reliable pattern:

1. 4 weeks out: Identify which companies are presenting (abstract lists are published)
2. 3 weeks out: Enter positions in stocks with the most anticipated data
3. Abstract release: At ASCO/ASH, abstracts release 2-3 weeks early. This is the first binary event.
4. Presentation day: Second binary event. Late-breaking data can surprise in either direction.

Key Signals

• Late-breaking abstract acceptance: This means the data is significant enough that organizers made special room for it. Very bullish signal.
• Oral presentation vs poster: Oral presentations are given to the most important data. Poster presentations are less impactful.
• Updated data vs new data: Completely new datasets move stocks more than updates to previously presented data.

2026 Conference Calendar Highlights

• AACR: April 17-22 in San Diego (oncology focus)
• AAN: April 25 – May 1 in San Diego (neurology focus)
• ASCO: May 29 – June 2 in Chicago (oncology, biggest event of the year)
• EHA: June 11-14 in Milan (hematology)
• ASH: December 5-8 in San Diego (hematology, year-end catalyst)

Track Conference Catalysts with BioRadar

BioRadar maintains a Conference Calendar with all 16 major biotech conferences, countdown timers, and focus areas. Combined with our catalyst calendar and drug pipeline data, you can identify which stocks in your watchlist have upcoming conference presentations.

Create a free account and never miss a conference catalyst again.

This article is for educational purposes only and does not constitute financial advice.